Yayın:
Are All Low GCS Patients Potential Organ Donors? Insights From a Policy-Driven Brain Death Evaluation Framework

dc.contributor.authorFatih Alper Ayyıldız
dc.contributor.authorGülgün Uncu
dc.contributor.authorAyşe Ayyıldız
dc.contributor.orcid0000-0002-2502-1030
dc.date.accessioned2026-05-20T10:19:46Z
dc.date.issued2026-03-02
dc.identifier.doi10.1016/j.transproceed.2026.02.011
dc.identifier.endpage407
dc.identifier.issn0041-1345
dc.identifier.issue3
dc.identifier.openalexW7133214236
dc.identifier.startpage403
dc.identifier.urihttps://hdl.handle.net/11421/39781
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2026.02.011
dc.identifier.volume58
dc.language.isoen
dc.relation.ispartofTransplantation Proceedings
dc.rightsrestrictedAccess
dc.subjectReferral
dc.subjectIdentification (biology)
dc.subjectMEDLINE
dc.subjectCause of death
dc.subjectCentral nervous system disease
dc.subjectRisk assessment
dc.titleAre All Low GCS Patients Potential Organ Donors? Insights From a Policy-Driven Brain Death Evaluation Framework
dspace.entity.typePublication

Dosyalar

Koleksiyonlar